Your gift is 100% tax deductible.
Chemotherapy for Soft Tissue Sarcomas
Chemotherapy (chemo) is treatment with anti-cancer drugs. These drugs are given by vein or by mouth to treat some people with soft tissue sarcomas.
When is chemo used?
Depending on the type and stage of sarcoma, chemotherapy might be given as the main treatment or after surgery. Different types of sarcomas respond better to chemo than others. A combination of several chemo drugs is generally used to treat soft tissue sarcomas.
Chemo drugs used for soft tissue sarcomas
The most common chemo drugs used are:
- Ifosfamide (Ifex®): Given with mesna (not a chemo drug) to protect the bladder from toxic side effects
- Doxorubicin (Adriamycin®)
Other chemo drugs might be used as well, including:
- Liposomal Doxorubicin (Doxil)
- Dacarbazine (DTIC)
- Epirubicin (Ellence)
- Temozolomide (Temodar®)
- Docetaxel (Taxotere®)
- Gemcitabine (Gemzar®)
- Vinorelbine (Navelbine®)
- Trabectedin (Yondelis®)
- Eribulin (Halaven®)
When several drugs are used together, the combination is given a shortened name such as: AIM (Adriamycin [doxorubicin], ifosfamide, and mesna) or Gem-Tax (gemcitabine and docetaxel).
Isolated limb perfusion (ILP)
ILP is a different way to give chemo. The circulation of the limb (arm or leg) with the tumor is separated from the rest of the body. Chemo is then given just to that limb. Sometimes the blood is warmed up a bit to help the chemo work better, a method called hyperthermia.
ILP might be used to treat tumors that cannot be removed or to treat high-grade tumors before surgery. It can help shrink tumors, but it isn’t clear that it helps patients live longer than standard chemo. ILP should only be done at centers with a lot of experience giving chemo this way.
Possible side effects
Chemo drugs kill cancer cells but also damage some normal cells. This causes side effects. Side effects depend on the type of drugs, the amount taken, and the length of treatment. Common chemo side effects include:
- Nausea and vomiting
- Loss of appetite
- Loss of hair
- Mouth sores
- Fatigue
- Low blood counts
Because chemotherapy can damage the blood-producing cells of the bone marrow, patients might have low blood cell counts. This can result in:
- Increased chance of infection from too few white blood cells
- Problems with bleeding or bruising from too few blood platelets
- Fatigue and weakness from too few red blood cells
Most side effects go away over time once treatment is stopped. For instance, hair will grow back after treatment ends, but it might look different. There are treatments for many of the short-term side effects of chemo. For instance, drugs can be given that prevent or reduce nausea and vomiting.
Possible long-term side effects
Some chemo side effects can last a long time or even be permanent. For instance, doxorubicin can weaken the heart if too much is given. If you're going to get this drug, your doctor might check your heart function with special studies before starting this drug. The doctor will also check your heart function during therapy.
Some chemo drugs cause nerve damage, called neuropathy, leading to numbness, tingling, or even pain in the hands and feet.
Chemotherapy might also permanently damage ovaries or testicles, causing infertility (not being able to have children). For more information, see Fertility Problems.
More information about chemotherapy
For more general information about how chemotherapy is used to treat cancer, see Chemotherapy.
To learn about some of the side effects listed here and how to manage them, see Managing Cancer-related Side Effects.
- Written by
- References
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Colombo C, Baratti D, Kusamura S, Deraco M, Gronchi A. The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma. J Surg Oncol. 2015 Apr;111(5):570-9. doi: 10.1002/jso.23808. Epub 2014 Oct 28. PMID: 25351775.
Helman LJ, Maki RG. Sarcomas of soft tissue. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE. Abeloff‘s Clinical Oncology. 6th ed. Philadelphia, PA. Elsevier: 2019.
Liebner DA. The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma. J Surg Oncol. 2015 Apr;111(5):622-31. doi: 10.1002/jso.23866. Epub 2015 Jan 8. PMID: 25581912.
National Cancer Institute. Adult Soft Tissue Sarcoma Treatment (PDQ®)–Health Professional Version. February 21, 2025. Accessed at www.cancer.gov/types/soft-tissue-sarcoma/hp/adult-soft-tissue-treatment-pdq on Dec 2, 2025.
National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Soft Tissue Sarcoma, Version 1.2025 – May 2, 2025. Accessed at www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf on Nov 20, 2025.
Singer S, Maki R, O’Sullivan B. Soft tissue sarcoma In: DeVita VT, Heilman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 11th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2019.
Last Revised: February 9, 2026
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.


